MSH Capital Advisors LLC decreased its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 38.3% during the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 2,467 shares of the healthcare conglomerate’s stock after selling 1,530 shares during the quarter. MSH Capital Advisors LLC’s holdings in UnitedHealth Group were worth $905,000 at the end of the most recent reporting period.
Other hedge funds have also modified their holdings of the company. Cornerstone Advisory LLC lifted its holdings in UnitedHealth Group by 5.0% during the 3rd quarter. Cornerstone Advisory LLC now owns 2,275 shares of the healthcare conglomerate’s stock worth $835,000 after buying an additional 108 shares in the last quarter. Shah Wealth Advisors LLC purchased a new stake in shares of UnitedHealth Group during the third quarter worth $411,000. Bernicke Wealth Management Ltd. purchased a new stake in shares of UnitedHealth Group during the third quarter worth $1,315,000. Vista Capital Partners Inc. acquired a new stake in shares of UnitedHealth Group in the third quarter valued at $202,000. Finally, Cornerstone Advisors LLC boosted its holdings in UnitedHealth Group by 117.2% in the third quarter. Cornerstone Advisors LLC now owns 64,287 shares of the healthcare conglomerate’s stock valued at $23,598,000 after purchasing an additional 34,688 shares during the period. 87.86% of the stock is currently owned by hedge funds and other institutional investors.
More UnitedHealth Group News
Here’s some of the latest news about UNH:
- Positive Sentiment: ETF flows were supportive: 51 ETFs bought UNH while nine sold shares on Nov. 11, for reported net ETF buying of $86.8 million. Article: UnitedHealth Sees $86.8 Million in Net ETF Buying
- Positive Sentiment: Recent commentary says analysts remain optimistic, and another article argues the shares may still be below fair value. It cites board changes and a sharper focus on medical-cost management and pricing as factors that could support earnings, though valuation depends on execution. Article: Do Wall Street Analysts Like UnitedHealth Group Stock? Article: UnitedHealth Group Stock Still Looks Below Fair Value After Board Appointment
- Neutral Sentiment: A technical analysis described UNH as consolidating, with neutral momentum and thin volume, suggesting no strong near-term signal from trading activity. Article: UnitedHealth Stock Price Prediction
Insiders Place Their Bets
In other UnitedHealth Group news, CEO Patrick Conway sold 1,169 shares of the firm’s stock in a transaction that occurred on Friday, August 21st. The shares were sold at an average price of $390.00, for a total transaction of $455,910.00. Following the sale, the chief executive officer owned 15,328 shares of the company’s stock, valued at approximately $5,977,920. This trade represents a 7.09% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 0.19% of the company’s stock.
UnitedHealth Group Stock Up 0.0%
UnitedHealth Group stock opened at $407.62 on Monday. The stock has a market cap of $365.23 billion, a PE ratio of 23.28, a P/E/G ratio of 1.47 and a beta of 0.51. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.74 and a quick ratio of 0.74. The stock’s fifty day moving average is $391.36 and its two-hundred day moving average is $365.66. UnitedHealth Group Incorporated has a 1-year low of $255.96 and a 1-year high of $461.62.
UnitedHealth Group (NYSE:UNH – Get Free Report) last released its quarterly earnings data on Tuesday, October 13th. The healthcare conglomerate reported $4.69 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.14 by $0.55. UnitedHealth Group had a return on equity of 17.95% and a net margin of 3.53%. The business had revenue of $112.72 billion during the quarter, compared to analysts’ expectations of $111.31 billion. During the same period in the prior year, the firm posted $2.59 EPS. The business’s quarterly revenue was down .4% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. On average, sell-side analysts expect that UnitedHealth Group Incorporated will post 20.61 EPS for the current fiscal year.
UnitedHealth Group Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 15th. Shareholders of record on Monday, December 7th will be paid a $2.32 dividend. This represents a $9.28 annualized dividend and a yield of 2.3%. The ex-dividend date is Monday, December 7th. UnitedHealth Group’s dividend payout ratio is currently 53.00%.
Analyst Upgrades and Downgrades
UNH has been the topic of several recent research reports. Bank of America restated a “buy” rating and set a $450.00 price target on shares of UnitedHealth Group in a report on Monday, July 20th. Piper Sandler boosted their price objective on UnitedHealth Group from $502.00 to $504.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 14th. New Street Research set a $402.00 target price on shares of UnitedHealth Group in a research note on Friday, October 9th. Morgan Stanley raised their target price on shares of UnitedHealth Group from $529.00 to $531.00 and gave the company an “overweight” rating in a report on Tuesday, October 27th. Finally, Wall Street Zen upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Saturday, August 8th. Twenty analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the stock. Based on data from MarketBeat, UnitedHealth Group has a consensus rating of “Moderate Buy” and a consensus price target of $463.93.
Read Our Latest Research Report on UnitedHealth Group
UnitedHealth Group Profile
UnitedHealth Group is a diversified health care company that provides health benefits and health services through two main businesses: UnitedHealthcare and Optum. UnitedHealthcare offers health insurance and related benefit plans to individuals, employers and government programs, including Medicare and Medicaid. Optum provides services across the health care system, including care delivery, pharmacy services, pharmacy benefit management, health technology and data analytics. Its businesses serve consumers, health care providers, employers, health plans and government organizations.
Featured Stories
- Five stocks we like better than UnitedHealth Group
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.
